Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

The Influence of MDR’s Article 117 in the Marketing of Combination Products

The European Union Medical Device Regulation’s (MDR) Article 117 brings improved patient safety measures with new implications for manufacturers, as they must fulfill a significant set of additional requirements.

Listen to the full episode on Veristat’s Advancing Revolutionary Therapies Podcast to learn more about the Article and its influence on the marketing of combination products.

Learning Points

  • What are Drug Device Combination (DDC) products
  • What is Article 117 of the MDR
  • The impact of Article 117 on Manufacturers

LISTEN TO PODCAST

 

Meet Veristat. Learn More.

Unlocking Insights: The Impact of New Medical Device EU Regulation (MDR)

Unlocking Insights: The Impact of New Medical Device EU Regulation (MDR)

Learn about the impact of the new EU Medical Device Regulation (MDR) on the development of medical devices and drug-device combination products. Gain...

Read More
Exploring Future Trends on European Regulations: A Webinar by Veristat and TOPRA

Exploring Future Trends on European Regulations: A Webinar by Veristat and TOPRA

Stay informed about the future trends in European regulations on medicines with Veristat and TOPRA. Explore the new Pharmaceutical Strategy for...

Read More
Regulatory Guidance Monthly Review - September 2023

Regulatory Guidance Monthly Review - September 2023

Stay updated with the latest regulatory guidance updates from the FDA in September 2023, including topics such as clinical trial regulations, drug...

Read More